Orthopedic Bone Cement Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Orthopedic bone cement is a fast-setting PMMA biomaterial used primarily to fix prosthetic components to bone during joint replacement and to augment fracture stabilization. The market is valued at roughly USD 1.34 billion in 2025 and is forecast to grow at about 5.61% annually, supported by rising surgical volumes worldwide. Demand is concentrated in hospitals and ambulatory surgical centers performing hip, knee, and shoulder arthroplasty as well as percutaneous vertebroplasty and kyphoplasty procedures.

• •Estimated 2025 market size of around USD 1.34 billion with a 5.61% CAGR
• •Primary clinical uses include cemented arthroplasty, vertebroplasty, kyphoplasty, and bone defect filling
• •Hospitals and ambulatory surgical centers are the main end-user channels

The principal growth driver is the rising global burden of musculoskeletal disease, particularly osteoarthritis and osteoporosis, which together generate sustained demand for joint replacement and vertebral augmentation procedures. Demographic aging in North America, Europe, and parts of Asia is increasing the pool of eligible surgical candidates, while improving access to elective orthopedic surgery in emerging markets is expanding the addressable patient base.

• •Aging populations in developed and emerging economies driving arthroplasty volumes
• •Increasing incidence of osteoporotic vertebral compression fractures
• •Expansion of orthopedic surgical capacity in Asia-Pacific and Latin America

The market is commonly segmented by product type into traditional PMMA cements, antibiotic-loaded cements, and bioactive or glass-ceramic formulations, with antibiotic-loaded variants holding a growing share due to infection-control priorities. By application, joint arthroplasty accounts for the largest share, followed by vertebroplasty/kyphoplasty and trauma fixation. North America and Europe currently lead in revenue terms, while Asia-Pacific is the fastest-growing region as surgical infrastructure and reimbursement systems mature.

• •Antibiotic-loaded bone cement is the fastest-growing product sub-segment
• •Joint arthroplasty dominates application mix; vertebroplasty and kyphoplasty are growing rapidly
• •North America leads revenue; Asia-Pacific is the highest-growth regional market

What are the recent trends and outlook?

Near-term trends include the development of antibiotic-eluting and antimicrobial cements designed to reduce periprosthetic joint infection, as well as bioactive and resorbable composites that may eventually supplement traditional PMMA. Regulatory pressure on conventional high-dose antibiotic cements in Europe and rising interest in personalized cement mixing systems are reshaping product portfolios. The market outlook through 2030 remains positive, with mid-single-digit annual growth driven primarily by procedure volume expansion rather than price inflation.

• •Shift toward antibiotic-loaded and antimicrobial cement formulations to combat surgical site infections
• •Bioactive additives and improved handling/viscosity profiles are key areas of innovation
• •Long-term growth is underpinned by procedure volume gains tied to aging demographics